Deciphera Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCPH and other ETFs, options, and stocks.About DCPH
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors.
DCPH Key Statistics
DCPH News
Loading... Loading... In the last three months, 5 analysts have published ratings on Deciphera Pharmaceuticals DCPH, offering a diverse range of perspectives f...
ONO Pharmaceutical (OTCPK:OPHLY) to acquire all outstanding shares of Deciphera Pharmaceuticals (NASDAQ:DCPH) for $25.60 per share in cash through a tender offe...
Deciphera Pharmaceuticals, Inc. ( ) shares have continued their recent momentum with a 61% gain in the last month alone. The last 30 days bring the annual gain...
Analyst ratings
70%
of 10 ratingsMore DCPH News
Loading... Loading... U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Monday. Following the market opening...
Loading... Loading... U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday. Shares of Tesla, Inc. TSLA rose sharply during Mond...
Deciphera Pharmaceuticals (NASDAQ:DCPH) announced on Monday that Japan’s ONO Pharmaceutical has agreed to acquire the cancer drug developer for a total equity v...
Dive Brief: Ono Pharmaceutical has agreed to buy cancer drugmaker Deciphera Pharmaceuticals in a deal that values the latter company at $2.4 billion. Per deal...
